| Etanercept |
EU/1/99/126/020 |
ENBREL, Solution for injection, 50 mg/ml – 1 ml, mg, Pack: 4 pre-filled pens +4 alcohol swabs |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство |
1263.78 |
252.76 |
1516.54 |
4% |
10 |
1273.78 |
254.76 |
1528.54 |
16% |
25 |
1298.78 |
259.76 |
1558.54 |
|
НСР-7900/25.01.2016.; НСР-12377/18.04.2017; НСР-15118/26.02.2018( предварително изпълнение) |
26.02.2018 |
02.03.2018 |
Неактивен |
3823 |
| Etanercept |
EU/1/99/126/020 |
ENBREL, Solution for injection, 50 mg/ml – 1 ml, mg, Pack: 4 pre-filled pens +4 alcohol swabs |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство |
1362.37 |
272.47 |
1634.84 |
4% |
10 |
1372.37 |
274.47 |
1646.84 |
16% |
25 |
1397.37 |
279.47 |
1676.84 |
|
НСР-7900/25.01.2016.; НСР-12377/18.04.2017 |
03.05.2017 |
02.06.2017 |
Неактивен |
3823 |
| Etanercept |
EU/1/99/126/003 |
ENBREL 25, Powder and solvent for solution for injection, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, Великобритания |
681.18 |
136.24 |
817.42 |
4% |
10 |
691.18 |
138.24 |
829.42 |
16% |
25 |
716.18 |
143.24 |
859.42 |
|
НСР-8334/26.02.2016; НСР-12836/26.05.2017 |
10.06.2017 |
02.07.2017 |
Неактивен |
3361 |
| Etanercept |
EU/1/99/126/012 |
ENBREL 25 mg powder and solvent for solution for injection for pediatric use 25 mg/ml - 1 ml x 4 vials + 4 pre-filled syringes + 8 syringes + 20 needles + 24 alcohol swabs, powder and solvent for solution for injection for pediatric use, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
874.12 |
174.82 |
1048.94 |
4% |
10 |
884.12 |
176.82 |
1060.94 |
16% |
25 |
909.12 |
181.82 |
1090.94 |
оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; Цената се заличавас решение НСР-2572/24.01.2014 |
КЦРР-2426/22.02.2013 |
16.10.2013 |
16.10.2013 |
Заличен |
2136 |
| Etanercept |
EU/1/99/126/012 |
ENBREL 25 mg powder and solvent for solution for injection for pediatric use 25 mg/ml - 1 ml x 4 vials + 4 pre-filled syringes + 8 syringes + 20 needles + 24 alcohol swabs, powder and solvent for solution for injection for pediatric use, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
926.3 |
185.26 |
1111.56 |
4% |
10 |
936.3 |
187.26 |
1123.56 |
16% |
25 |
961.3 |
192.26 |
1153.56 |
промяна в обстоятелствата КЦPP-1521/25.10.2012 |
КЦ-316/28.11.2008 |
19.12.2008 |
19.12.2008 |
Неактивен |
2136 |
| Etanercept |
EU/1/99/126/013 |
ENBREL 25 mg solution for injection in pre-filled syringe 50 mg/ml - 0,5 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, Великобритания |
853.07 |
170.61 |
1023.68 |
4% |
10 |
863.07 |
172.61 |
1035.68 |
16% |
25 |
888.07 |
177.61 |
1065.68 |
оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; Цената се заличавас решение НСР-2573/24.01.2014 |
КЦРР-2426/22.02.2013 |
16.10.2013 |
16.10.2013 |
Заличен |
2135 |
| Etanercept |
EU/1/99/126/013 |
ENBREL 25 mg solution for injection in pre-filled syringe 50 mg/ml - 0,5 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, Великобритания |
926.3 |
185.26 |
1111.56 |
4% |
10 |
936.3 |
187.26 |
1123.56 |
16% |
25 |
961.3 |
192.26 |
1153.56 |
промяна в обстоятелствата КЦPP-1521/25.10.2012 |
КЦ-316/28.11.2008 |
19.12.2008 |
19.12.2008 |
Неактивен |
2135 |
| Etanercept |
EU/1/99/126/003 |
ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, Великобритания |
702.67 |
140.53 |
843.2 |
4% |
10 |
712.67 |
142.53 |
855.2 |
16% |
25 |
737.67 |
147.53 |
885.2 |
|
НСР-8334/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
3361 |
| Etanercept |
EU/1/99/126/003 |
ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, Великобритания |
789.12 |
157.82 |
946.94 |
4% |
10 |
799.12 |
159.82 |
958.94 |
16% |
25 |
824.12 |
164.82 |
988.94 |
|
НСР-5033/17.11.2014 |
01.12.2014 |
01.12.2014 |
Неактивен |
3361 |
| Etanercept |
EU/1/99/126/003 |
ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, Великобритания |
874.12 |
174.82 |
1048.94 |
4% |
10 |
884.12 |
176.82 |
1060.94 |
16% |
25 |
909.12 |
181.82 |
1090.94 |
Отхвърлена жалба от Комисия по прозрчаност с решение КП-260/18.12.2013 |
НСР-73/07.06.2013 |
16.03.2014 |
16.03.2014 |
Неактивен |
3361 |
| Etanercept |
EU/1/99/126/003 |
ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, Великобритания |
926.3 |
185.26 |
1111.56 |
4% |
10 |
936.3 |
187.26 |
1123.56 |
16% |
25 |
961.3 |
192.26 |
1153.56 |
промяна в обстоятелствата КЦPP-1521/25.10.2012 |
КЦ-397/07.01.2009 |
30.01.2009 |
30.01.2009 |
Неактивен |
3361 |
| Etanercept |
EU/1/99/126/020 |
ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство |
1405.36 |
281.07 |
1686.43 |
4% |
10 |
1415.36 |
283.07 |
1698.43 |
16% |
25 |
1440.36 |
288.07 |
1728.43 |
|
НСР-7900/25.01.2016. |
09.02.2016 |
09.02.2016 |
Неактивен |
3823 |
| Etanercept |
EU/1/99/126/020 |
ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство |
1561.96 |
312.39 |
1874.35 |
4% |
10 |
1571.96 |
314.39 |
1886.35 |
16% |
25 |
1596.96 |
319.39 |
1916.35 |
|
НСР-6072/23.04.2015. |
08.05.2015 |
08.05.2015 |
Неактивен |
3823 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Europe MA EEIG, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1405.36 |
281.07 |
1686.43 |
4% |
10 |
1415.36 |
283.07 |
1698.43 |
16% |
25 |
1440.36 |
288.07 |
1728.43 |
|
НСР-7813/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Europe MA EEIG, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1561.96 |
312.39 |
1874.35 |
4% |
10 |
1571.96 |
314.39 |
1886.35 |
16% |
25 |
1596.96 |
319.39 |
1916.35 |
|
НСР-5949/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1622.03 |
324.41 |
1946.44 |
4% |
10 |
1632.03 |
326.41 |
1958.44 |
16% |
25 |
1657.03 |
331.41 |
1988.44 |
|
НСР-3992/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1739.08 |
347.82 |
2086.9 |
4% |
10 |
1749.08 |
349.82 |
2098.9 |
16% |
25 |
1774.08 |
354.82 |
2128.9 |
оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; |
КЦРР-2426/22.02.2013 |
16.10.2013 |
16.10.2013 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1852.6 |
370.52 |
2223.12 |
4% |
10 |
1862.6 |
372.52 |
2235.12 |
16% |
25 |
1887.6 |
377.52 |
2265.12 |
промяна в обстоятелствата КЦPP-1521/25.10.2012 |
КЦ-316/28.11.2008 |
19.12.2008 |
19.12.2008 |
Неактивен |
3736 |
| Macrogol, combinations |
20060822 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
14.14 |
2.83 |
16.97 |
6% |
0.85 |
14.99 |
3 |
17.99 |
18% |
2.55 |
17.54 |
3.51 |
21.05 |
Промяна на обстоятелства НСР-13979/25.09.2017; НСР-16103/13.07.2018 |
КЦРР-1094/26.07.2012; НСР-16104/13.07.2018 |
02.08.2018 |
02.08.2018 |
Активен |
1310 |
| Macrogol, combinations |
20060822 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
10.07 |
2.01 |
12.08 |
6% |
0.6 |
10.67 |
2.13 |
12.8 |
18% |
1.81 |
12.48 |
2.5 |
14.98 |
Промяна на обстоятелства НСР-13979/25.09.2017 |
КЦРР-1094/26.07.2012 |
10.08.2012 |
02.11.2017 |
Неактивен |
1310 |
| Macrogol, combinations |
5378/ 13.07.2009 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
10.07 |
2.01 |
12.08 |
6% |
0.6 |
10.67 |
2.13 |
12.8 |
18% |
1.81 |
12.48 |
2.5 |
14.98 |
|
КЦРР-1094/26.07.2012 |
10.08.2012 |
10.08.2012 |
Неактивен |
1310 |
| Macrogol, combinations |
5378/13.07.2009 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
12.3 |
2.46 |
14.76 |
8% |
0.98 |
13.28 |
2.66 |
15.94 |
20% |
2.46 |
15.74 |
3.15 |
18.89 |
|
КЦ-1412/22.02.2010 |
10.03.2010 |
10.03.2010 |
Неактивен |
1310 |
| Cyclophosphamide |
20020299 |
Endoxan, Powder for solution for injection, 500, mg, Pack: 1 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
20.73 |
4.15 |
24.88 |
6% |
1.24 |
21.97 |
4.39 |
26.36 |
18% |
3.73 |
25.7 |
5.14 |
30.84 |
|
НСР-13864/14.09.2017 |
29.09.2017 |
02.10.2017 |
Активен |
15853 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 |
КЦРР-2309/20.02.2013; НСР-15268/16.03.2018 |
08.03.2013 |
02.04.2018 |
Заличен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 |
КЦРР-2309/20.02.2013 |
08.03.2013 |
02.10.2017 |
Неактивен |
1666 |